Although our data support the hyperinsulinemia-causes-IR hypothesis, short-term PRKD2 inhibition or deficiency may have beneficial effect via enhancing glucose-stimulated insulin secretion. This evidence concerns the gene PRKD2 and hyperinsulinism.